AboutVysioneer

Vysioneer is an oncology AI company with a mission to use machine learning to bring therapies to cancer patients in need sooner. Our journey began with the belief that every tumor matters in the fight against cancer.

Powered by our FDA-cleared, cloud-based AI platform, Vysioneer enhances drug efficacy with lesion-level precision, enabling pharma and clinicians to identify the right treatment for the right patient at the right time. Vysioneer is headquartered in Cambridge, MA.

Leadership

Jen-Tang (JT) Lu

Jen-Tang (JT) Lu, PhD

Founder and CEO

Advisors

Roger W. Ferguson, Jr.

Roger W. Ferguson, Jr., J.D., PhD

Business advisor

Former President and CEO at TIAA

Joe Chang

Joe Chang, ScD

Business Advisor

Ex-Flatiron Health and Ex-IQVIA

Christopher Ballesteros

Christopher Ballesteros

Business advisor

Chief Commercial Officer, KangarooHealth Inc.

Chih-Han Yu

Chih-Han Yu, PhD

Business Advisor

Co-founder and CEO, Appier

Lawrence Leighton

Lawrence Leighton, MBA

Business Advisor

Managing Director, Bentley Associates

Peter Steiger

Peter Steiger, PhD

Business Advisor

Former Chief Scientific Officer, CALYX

Erqi Pollom

Erqi Pollom, MD

Medical Advisor

Radiation Oncologist, Stanford Cancer Center

Raymond Y. Huang

Raymond Y. Huang, MD, PhD

Medical Advisor

Division Chief, Neuroradiology, Brigham and Women's Hospital

Jason Cheng

Jason Cheng, MD, PhD

Medical Advisor

Former Division Chief, Radiation Oncology, National Taiwan University Hospital

Ryan King

Ryan King, MD

Medical Advisor

Neuroradiologist, LCMC Health

Career

Join a team of world-leading experts passionate about making a global impact on cancer care through leading innovations built from scratch.

Full-Stack Software Engineer

Taipei, Taiwan, Full-Time

Director, Business Development

Cambridge, MA, Full-Time

Machine Learning Scientist

Taipei, Taiwan, Full-Time

PM and Quality Assurance/Regulatory Affairs

Taipei, Taiwan, Full-Time